Previous meta-analysis and systematic reviews confirmed that active vitamin D analogs suppress parathyroid hormone (PTH) and reduce proteinuria in CKD patients without increasing the risk of adverse events [11,12]. This evidence concerns the gene PTH and chronic kidney disease.